Trial intelligence / Profile preview

Atorvastatin therapy in intensive care patients with sepsis

ChiCTR-TRC-14004134Phase 4Completed

Sponsor
The First Affiliated Hospital of Zhengzhou University
Start
Feb 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in sepsis comparing Atorvastatin with Placebo (2 arms). Primary endpoints: ICU mortality, 14-day mortality and 1 more. Started Feb 2014; status: completed.

02

Drugs

atorvastatin
03

Conditions

sepsis

Beyond the preview

Go deeper on ChiCTR-TRC-14004134.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-14004134.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call